TOFACITINIB CITRATE
Disclaimer: These predictions are for research purposes only. They do not constitute medical advice and require clinical validation.
Overview
| Property | Value |
|---|---|
| Drug Name | TOFACITINIB CITRATE |
| DrugBank ID | DB08895 |
| HSA Status | Registered with Health Sciences Authority |
| KG Predictions | 9 |
| DL Predictions (≥0.7) | 13 |
Predicted Indications
The following indications are predicted based on TxGNN knowledge graph analysis:
| Indication | Source | Evidence |
|---|---|---|
| primary myelofibrosis | TxGNN Knowledge Graph | L5 |
| plasmacytoma | TxGNN Knowledge Graph | L5 |
| polycythemia (disease) | TxGNN Knowledge Graph | L5 |
| myeloproliferative neoplasm | TxGNN Knowledge Graph | L5 |
| myelofibrosis | TxGNN Knowledge Graph | L5 |
| bone marrow neoplasm | TxGNN Knowledge Graph | L5 |
| acquired polycythemia vera | TxGNN Knowledge Graph | L5 |
| pulmonary arterial hypertension | TxGNN Knowledge Graph | L5 |
| skin disease caused by infection | TxGNN Knowledge Graph | L5 |
Evidence Summary
External Resources
Generated by SgTxGNN on 2026-03-11